Fiduciary Trust International of Pennsylvania’s West Pharmaceutical WST Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$2.66M	Buy	+17,454	New	+$2.69M	0.12%	147

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's WST Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania opened a new position in West Pharmaceutical (WST) in Q1 2020: 17,454 shares worth $2.66M. The stake represents 0.12% of the portfolio and ranks #147 among its holdings.

469 funds tracked by Wall St. Rank hold WST as of Q1 2020.

Fiduciary Trust International of Pennsylvania held 17,454 shares of West Pharmaceutical worth $2.66M as of Q1 2020.
West Pharmaceutical was a new Fiduciary Trust International of Pennsylvania position in Q1 2020.
West Pharmaceutical made up 0.12% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #147 holding.
469 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.